🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 5 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/12/2005 | 35,90 | 36,30 | 35,76 | 36,19 | +2,16% | 1,52% | 505.400 |
| 21/12/2005 | 34,94 | 35,65 | 34,89 | 35,42 | +1,40% | 2,16% | 537.200 |
| 20/12/2005 | 34,49 | 35,34 | 34,40 | 34,93 | +1,16% | 2,71% | 643.000 |
| 19/12/2005 | 35,91 | 36,06 | 33,89 | 34,53 | -2,86% | 6,04% | 1.311.600 |
| 16/12/2005 | 35,61 | 36,01 | 35,05 | 35,55 | -0,21% | 2,68% | 700.200 |
| 15/12/2005 | 35,32 | 35,76 | 34,70 | 35,62 | +0,76% | 3,00% | 509.400 |
| 14/12/2005 | 35,98 | 36,18 | 34,98 | 35,35 | -1,68% | 3,34% | 436.600 |
| 13/12/2005 | 35,13 | 36,15 | 35,07 | 35,96 | +2,23% | 3,09% | 515.000 |
| 12/12/2005 | 35,53 | 35,75 | 34,70 | 35,17 | -0,78% | 2,96% | 786.800 |
| 09/12/2005 | 35,61 | 35,90 | 34,65 | 35,45 | -0,38% | 3,51% | 386.400 |
| 08/12/2005 | 35,47 | 35,81 | 35,19 | 35,58 | +0,08% | 1,76% | 361.000 |
| 07/12/2005 | 36,22 | 36,50 | 35,08 | 35,55 | -1,93% | 3,93% | 559.000 |
| 06/12/2005 | 36,84 | 37,66 | 36,24 | 36,25 | -1,84% | 3,86% | 567.800 |
| 05/12/2005 | 36,83 | 37,08 | 35,94 | 36,93 | +0,24% | 3,10% | 330.600 |
| 02/12/2005 | 36,37 | 36,94 | 35,73 | 36,84 | +1,22% | 3,33% | 479.000 |
| 01/12/2005 | 35,94 | 36,65 | 35,79 | 36,40 | +1,90% | 2,41% | 313.600 |
| 30/11/2005 | 35,66 | 36,35 | 35,39 | 35,72 | -0,10% | 2,69% | 520.400 |
| 29/11/2005 | 35,74 | 36,18 | 35,58 | 35,75 | +0,14% | 1,69% | 421.000 |
| 28/11/2005 | 37,28 | 37,28 | 35,24 | 35,70 | -3,46% | 5,49% | 1.172.200 |
| 25/11/2005 | 37,19 | 37,19 | 36,52 | 36,98 | -0,30% | 1,80% | 170.000 |
| 23/11/2005 | 37,51 | 37,95 | 36,78 | 37,09 | -1,30% | 3,12% | 322.000 |
| 22/11/2005 | 37,74 | 37,89 | 36,92 | 37,58 | -0,62% | 2,57% | 531.400 |
| 21/11/2005 | 36,97 | 37,98 | 36,23 | 37,82 | +2,33% | 4,72% | 516.800 |
| 18/11/2005 | 37,53 | 37,89 | 36,70 | 36,96 | -1,23% | 3,18% | 658.400 |
| 17/11/2005 | 36,07 | 37,45 | 36,07 | 37,42 | +3,64% | 3,83% | 710.000 |
| 16/11/2005 | 36,40 | 36,59 | 35,76 | 36,10 | -0,30% | 2,28% | 386.600 |
| 15/11/2005 | 35,50 | 36,68 | 35,33 | 36,21 | +1,84% | 3,79% | 853.000 |
| 14/11/2005 | 36,77 | 37,05 | 35,14 | 35,56 | -2,86% | 5,18% | 1.068.200 |
| 11/11/2005 | 36,39 | 36,73 | 35,88 | 36,60 | +0,97% | 2,35% | 771.200 |
| 10/11/2005 | 36,46 | 36,75 | 35,40 | 36,25 | -0,85% | 3,70% | 958.200 |